Federal Circuit affirms PTAB unpatentability of most claims of Centripetal Networks’ cybersecurity patent, then reverses PTAB on cross-appeal to find all 20 claims obvious — wiping out the patent entirely.
Federal Circuit affirms ITC finding of no Section 337 violation in Centripetal Networks’ cybersecurity patent dispute against Keysight Technologies, citing failure to satisfy the domestic industry technical prong.
Federal Circuit affirms that two augmented-reality patents asserted against Pokémon Go and Harry Potter: Wizards Unite are invalid as abstract ideas under § 101.
Federal Circuit revives one patent claim against YouTube’s Siberia Content ID system while affirming two others invalid for indefiniteness.
The Federal Circuit dismissed a §101 patent eligibility appeal as moot after discovering the parties’ settlement agreement gave the defendant a $100 option to license the challenged patent — an amount so untethered from the patent’s value that it created no real case or controversy.
The Federal Circuit affirmed PTAB decisions invalidating Katana Silicon’s semiconductor stacking patents after holding that “adhesion layer” means any layer that adheres, not only a pre-formed solid sheet, bringing the claims within the scope of prior art.
The Federal Circuit reversed a $17 million trade secret verdict, holding that design concepts disclosed in prior patents are generally known and unprotectable as trade secrets even if never commercialized, while affirming a $1 million Lanham Act counterfeiting judgment.
The Federal Circuit denied FullView’s § 1292(b) petition to take an immediate appeal from district court rulings that invalidated some patent claims under § 101 and excluded FullView’s damages expert, leaving both rulings in place until final judgment.
The Federal Circuit reversed a judgment invalidating Teva’s method-of-treatment patents covering anti-CGRP antibodies for migraines, distinguishing Amgen v. Sanofi and reinstating a jury verdict against Eli Lilly.
The Federal Circuit affirmed the PTAB’s cancellation of MRI’s outdoor display cooling patent claims via Rule 36, completing Samsung’s successful IPR challenge to the patent family.